Please Wait
Applying Filters...
menu
    • menu
    Default Key Product, Service and Excipients
    News
    Shamrock Pharmachemi Acquires Full Control Of Unimark Remedies

    28 Nov 2024

    // PRESS RELEASE

    Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies

    18 Apr 2023

    // ECONOMIC TIMES

    Shamrock Biopharma closes 304 M yuan in Series B financing

    28 Nov 2019

    // BIOSPECTRUM ASIA

    Data Compilation
    #PharmaFlow

    Read More

    Contact Supplier

    Website

    APS Symposium

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
    Menu

    Shamrock Pharmachemi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/shamrock-pharmachemi-party-content-40761.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Shamrock Pharmachemi Acquires Full Control Of Unimark Remedies
    Shamrock Pharmachemi Acquires Full Control Of Unimark Remedies

    28 Nov 2024

    // PRESS RELEASE

    https://unimarkremedies.com/there-has-been-change-in-ownership-of-manage-by-shamrock-pharmagroup/

    PRESS RELEASE
    28 Nov 2024
    Share Share
    Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies
    Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies

    18 Apr 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/intas-shamrock-plan-for-unimark-remedies-gets-nod-from-nclt/articleshow/99566841.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    18 Apr 2023
    Share Share
    Shamrock Biopharma closes 304 M yuan in Series B financing
    Shamrock Biopharma closes 304 M yuan in Series B financing

    28 Nov 2019

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/26/14988/shamrock-biopharma-closes-304-m-yuan-in-series-b-financing.html

    BIOSPECTRUM ASIA
    28 Nov 2019
    Share Share
    Contact Shamrock Pharmachemi and get a quotation

    Shamrock Pharmachemi is a supplier offers 10 products (APIs, Excipients or Intermediates).

    Find a price of Biapenem bulk offered by Shamrock Pharmachemi

    Find a price of Drotaverine bulk offered by Shamrock Pharmachemi

    Find a price of Ertapenem bulk offered by Shamrock Pharmachemi

    Find a price of Faropenem bulk offered by Shamrock Pharmachemi

    Find a price of Flecainide bulk offered by Shamrock Pharmachemi

    Find a price of Imipenem bulk offered by Shamrock Pharmachemi

    Find a price of Lisinopril bulk offered by Shamrock Pharmachemi

    Find a price of Montelukast Sodium bulk offered by Shamrock Pharmachemi

    Find a price of Nitrofurantoin bulk offered by Shamrock Pharmachemi

    Find a price of Tigecycline bulk offered by Shamrock Pharmachemi